The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Warfarin Market Research Report 2024

Global Warfarin Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1610556

No of Pages : 99

Ask Your Query

Synopsis

This report studies Warfarin Drugs market.

Global Warfarin market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Warfarin market research.

Key manufacturers engaged in the Warfarin industry include Qilu Pharma, Sine Pharma (Shanghai Pharma), Beijing Jialin Pharmaceutical, Henan Zhongjie Pharma, Shanghai Xudong Haipu Pharmaceutical (SunRise), Amneal Pharma, TEVA (Barr, PLIVA), Cipla (InvaGen) and Orion Corporation Orion Pharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Warfarin were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Warfarin market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Warfarin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company (Partial List)

  •     Qilu Pharma
  •     Sine Pharma (Shanghai Pharma)
  •     Beijing Jialin Pharmaceutical
  •     Henan Zhongjie Pharma
  •     Shanghai Xudong Haipu Pharmaceutical (SunRise)
  •     Amneal Pharma
  •     TEVA (Barr, PLIVA)
  •     Cipla (InvaGen)
  •     Orion Corporation Orion Pharma
  •     BRISTOL MYERS SQUIBB
  •     UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd)
  •     Zydus Pharmaceuticals (USA) Inc
  •     Taro Pharmaceutical Industries Ltd.
  •     IPCA LABS LTD

Segment by Type

  •     1mg/Tablet
  •     2.5mg/Tablet
  •     3mg/Tablet
  •     5mg/Tablet
  •     Others

Segment by Application

  •     Mechanical Heart Valves (MHV) Replacement
  •     Atrial Fibrillation (AF)
  •     Deep Vein Thrombosis (DVT)
  •     Pulmonary Embolism (PE)
  •     Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

The Warfarin report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

1 Warfarin Market Overview
    1.1 Product Overview and Scope of Warfarin
    1.2 Warfarin Segment by Type
        1.2.1 Global Warfarin Market Value Comparison by Type (2023-2029)
        1.2.2 1mg/Tablet
        1.2.3 2.5mg/Tablet
        1.2.4 3mg/Tablet
        1.2.5 5mg/Tablet
        1.2.6 Others
    1.3 Warfarin Segment by Application
        1.3.1 Global Warfarin Market Value by Application: (2023-2029)
        1.3.2 Mechanical Heart Valves (MHV) Replacement
        1.3.3 Atrial Fibrillation (AF)
        1.3.4 Deep Vein Thrombosis (DVT)
        1.3.5 Pulmonary Embolism (PE)
        1.3.6 Others
    1.4 Global Warfarin Market Size Estimates and Forecasts
        1.4.1 Global Warfarin Revenue 2018-2029
        1.4.2 Global Warfarin Sales 2018-2029
        1.4.3 Global Warfarin Market Average Price (2018-2029)
    1.5 Assumptions and Limitations

 2 Warfarin Market Competition by Manufacturers
    2.1 Global Warfarin Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Warfarin Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Warfarin Average Price by Manufacturers (2018-2023)
    2.4 Global Warfarin Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Warfarin, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Warfarin, Product Type & Application
    2.7 Warfarin Market Competitive Situation and Trends
        2.7.1 Warfarin Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Warfarin Players Market Share by Revenue
        2.7.3 Global Warfarin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Warfarin Retrospective Market Scenario by Region
    3.1 Global Warfarin Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Warfarin Global Warfarin Sales by Region: 2018-2029
        3.2.1 Global Warfarin Sales by Region: 2018-2023
        3.2.2 Global Warfarin Sales by Region: 2024-2029
    3.3 Global Warfarin Global Warfarin Revenue by Region: 2018-2029
        3.3.1 Global Warfarin Revenue by Region: 2018-2023
        3.3.2 Global Warfarin Revenue by Region: 2024-2029
    3.4 North America Warfarin Market Facts & Figures by Country
        3.4.1 North America Warfarin Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Warfarin Sales by Country (2018-2029)
        3.4.3 North America Warfarin Revenue by Country (2018-2029)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Warfarin Market Facts & Figures by Country
        3.5.1 Europe Warfarin Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Warfarin Sales by Country (2018-2029)
        3.5.3 Europe Warfarin Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Warfarin Market Facts & Figures by Country
        3.6.1 Asia Pacific Warfarin Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Warfarin Sales by Country (2018-2029)
        3.6.3 Asia Pacific Warfarin Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
    3.7 Latin America Warfarin Market Facts & Figures by Country
        3.7.1 Latin America Warfarin Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Warfarin Sales by Country (2018-2029)
        3.7.3 Latin America Warfarin Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Warfarin Market Facts & Figures by Country
        3.8.1 Middle East and Africa Warfarin Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Warfarin Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Warfarin Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

 4 Segment by Type
    4.1 Global Warfarin Sales by Type (2018-2029)
        4.1.1 Global Warfarin Sales by Type (2018-2023)
        4.1.2 Global Warfarin Sales by Type (2024-2029)
        4.1.3 Global Warfarin Sales Market Share by Type (2018-2029)
    4.2 Global Warfarin Revenue by Type (2018-2029)
        4.2.1 Global Warfarin Revenue by Type (2018-2023)
        4.2.2 Global Warfarin Revenue by Type (2024-2029)
        4.2.3 Global Warfarin Revenue Market Share by Type (2018-2029)
    4.3 Global Warfarin Price by Type (2018-2029)

 5 Segment by Application
    5.1 Global Warfarin Sales by Application (2018-2029)
        5.1.1 Global Warfarin Sales by Application (2018-2023)
        5.1.2 Global Warfarin Sales by Application (2024-2029)
        5.1.3 Global Warfarin Sales Market Share by Application (2018-2029)
    5.2 Global Warfarin Revenue by Application (2018-2029)
        5.2.1 Global Warfarin Revenue by Application (2018-2023)
        5.2.2 Global Warfarin Revenue by Application (2024-2029)
        5.2.3 Global Warfarin Revenue Market Share by Application (2018-2029)
    5.3 Global Warfarin Price by Application (2018-2029)

 6 Key Companies Profiled
    6.1 Qilu Pharma
        6.1.1 Qilu Pharma Corporation Information
        6.1.2 Qilu Pharma Description and Business Overview
        6.1.3 Qilu Pharma Warfarin Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 Qilu Pharma Warfarin Product Portfolio
        6.1.5 Qilu Pharma Recent Developments/Updates
    6.2 Sine Pharma (Shanghai Pharma)
        6.2.1 Sine Pharma (Shanghai Pharma) Corporation Information
        6.2.2 Sine Pharma (Shanghai Pharma) Description and Business Overview
        6.2.3 Sine Pharma (Shanghai Pharma) Warfarin Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 Sine Pharma (Shanghai Pharma) Warfarin Product Portfolio
        6.2.5 Sine Pharma (Shanghai Pharma) Recent Developments/Updates
    6.3 Beijing Jialin Pharmaceutical
        6.3.1 Beijing Jialin Pharmaceutical Corporation Information
        6.3.2 Beijing Jialin Pharmaceutical Description and Business Overview
        6.3.3 Beijing Jialin Pharmaceutical Warfarin Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 Beijing Jialin Pharmaceutical Warfarin Product Portfolio
        6.3.5 Beijing Jialin Pharmaceutical Recent Developments/Updates
    6.4 Henan Zhongjie Pharma
        6.4.1 Henan Zhongjie Pharma Corporation Information
        6.4.2 Henan Zhongjie Pharma Description and Business Overview
        6.4.3 Henan Zhongjie Pharma Warfarin Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Henan Zhongjie Pharma Warfarin Product Portfolio
        6.4.5 Henan Zhongjie Pharma Recent Developments/Updates
    6.5 Shanghai Xudong Haipu Pharmaceutical (SunRise)
        6.5.1 Shanghai Xudong Haipu Pharmaceutical (SunRise) Corporation Information
        6.5.2 Shanghai Xudong Haipu Pharmaceutical (SunRise) Description and Business Overview
        6.5.3 Shanghai Xudong Haipu Pharmaceutical (SunRise) Warfarin Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Shanghai Xudong Haipu Pharmaceutical (SunRise) Warfarin Product Portfolio
        6.5.5 Shanghai Xudong Haipu Pharmaceutical (SunRise) Recent Developments/Updates
    6.6 Amneal Pharma
        6.6.1 Amneal Pharma Corporation Information
        6.6.2 Amneal Pharma Description and Business Overview
        6.6.3 Amneal Pharma Warfarin Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 Amneal Pharma Warfarin Product Portfolio
        6.6.5 Amneal Pharma Recent Developments/Updates
    6.7 TEVA (Barr, PLIVA)
        6.6.1 TEVA (Barr, PLIVA) Corporation Information
        6.6.2 TEVA (Barr, PLIVA) Description and Business Overview
        6.6.3 TEVA (Barr, PLIVA) Warfarin Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 TEVA (Barr, PLIVA) Warfarin Product Portfolio
        6.7.5 TEVA (Barr, PLIVA) Recent Developments/Updates
    6.8 Cipla (InvaGen)
        6.8.1 Cipla (InvaGen) Corporation Information
        6.8.2 Cipla (InvaGen) Description and Business Overview
        6.8.3 Cipla (InvaGen) Warfarin Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 Cipla (InvaGen) Warfarin Product Portfolio
        6.8.5 Cipla (InvaGen) Recent Developments/Updates
    6.9 Orion Corporation Orion Pharma
        6.9.1 Orion Corporation Orion Pharma Corporation Information
        6.9.2 Orion Corporation Orion Pharma Description and Business Overview
        6.9.3 Orion Corporation Orion Pharma Warfarin Sales, Revenue and Gross Margin (2018-2023)
        6.9.4 Orion Corporation Orion Pharma Warfarin Product Portfolio
        6.9.5 Orion Corporation Orion Pharma Recent Developments/Updates
    6.10 BRISTOL MYERS SQUIBB
        6.10.1 BRISTOL MYERS SQUIBB Corporation Information
        6.10.2 BRISTOL MYERS SQUIBB Description and Business Overview
        6.10.3 BRISTOL MYERS SQUIBB Warfarin Sales, Revenue and Gross Margin (2018-2023)
        6.10.4 BRISTOL MYERS SQUIBB Warfarin Product Portfolio
        6.10.5 BRISTOL MYERS SQUIBB Recent Developments/Updates
    6.11 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd)
        6.11.1 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Corporation Information
        6.11.2 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Warfarin Description and Business Overview
        6.11.3 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Warfarin Sales, Revenue and Gross Margin (2018-2023)
        6.11.4 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Warfarin Product Portfolio
        6.11.5 UPSHER SMITH LABS (Sawai Pharmaceutical Co.,Ltd) Recent Developments/Updates
    6.12 Zydus Pharmaceuticals (USA) Inc
        6.12.1 Zydus Pharmaceuticals (USA) Inc Corporation Information
        6.12.2 Zydus Pharmaceuticals (USA) Inc Warfarin Description and Business Overview
        6.12.3 Zydus Pharmaceuticals (USA) Inc Warfarin Sales, Revenue and Gross Margin (2018-2023)
        6.12.4 Zydus Pharmaceuticals (USA) Inc Warfarin Product Portfolio
        6.12.5 Zydus Pharmaceuticals (USA) Inc Recent Developments/Updates
    6.13 Taro Pharmaceutical Industries Ltd.
        6.13.1 Taro Pharmaceutical Industries Ltd. Corporation Information
        6.13.2 Taro Pharmaceutical Industries Ltd. Warfarin Description and Business Overview
        6.13.3 Taro Pharmaceutical Industries Ltd. Warfarin Sales, Revenue and Gross Margin (2018-2023)
        6.13.4 Taro Pharmaceutical Industries Ltd. Warfarin Product Portfolio
        6.13.5 Taro Pharmaceutical Industries Ltd. Recent Developments/Updates
    6.14 IPCA LABS LTD
        6.14.1 IPCA LABS LTD Corporation Information
        6.14.2 IPCA LABS LTD Warfarin Description and Business Overview
        6.14.3 IPCA LABS LTD Warfarin Sales, Revenue and Gross Margin (2018-2023)
        6.14.4 IPCA LABS LTD Warfarin Product Portfolio
        6.14.5 IPCA LABS LTD Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Warfarin Industry Chain Analysis
    7.2 Warfarin Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Warfarin Production Mode & Process
    7.4 Warfarin Sales and Marketing
        7.4.1 Warfarin Sales Channels
        7.4.2 Warfarin Distributors
    7.5 Warfarin Customers

 8 Warfarin Market Dynamics
    8.1 Warfarin Industry Trends
    8.2 Warfarin Market Drivers
    8.3 Warfarin Market Challenges
    8.4 Warfarin Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock